Nebulization of pharmacological solutions with an innovative medical device based on microvaporization.

[1]  G. Du,et al.  Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5 , 2023, Cell Discovery.

[2]  P. Pandolfi,et al.  Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids , 2022, Cells.

[3]  M. Sullivan,et al.  Inhalable mRNA vaccines for respiratory diseases: a roadmap. , 2021, Current opinion in biotechnology.

[4]  Z. Cui,et al.  Intranasal vaccine: factors to consider in research and development. , 2021, International journal of pharmaceutics.

[5]  E. van Riet,et al.  An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection , 2021, bioRxiv.

[6]  G. Saraogi,et al.  A Recent Update on Intranasal Delivery of High Molecular Weight Proteins, Peptides, and Hormones. , 2021, Current pharmaceutical design.

[7]  P. Pandolfi,et al.  Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations , 2020, bioRxiv.

[8]  E. Lavelle,et al.  Mucosal vaccines — fortifying the frontiers , 2021, Nature Reviews Immunology.

[9]  Rachel L. Spreng,et al.  Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses , 2021, Nature.

[10]  Krishna R. Kalari,et al.  COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies , 2021, Molecular pharmaceutics.

[11]  S. Srivastava,et al.  Recent advances in the development of microparticles for pulmonary administration. , 2020, Drug discovery today.

[12]  J. Schreiber,et al.  Inhaler devices in asthma and COPD patients – a prospective cross-sectional study on inhaler preferences and error rates , 2020, BMC Pulmonary Medicine.

[13]  N. Mantis,et al.  An intranasally administered monoclonal antibody cocktail abrogates ricin toxin-induced pulmonary tissue damage and inflammation , 2020, Human vaccines & immunotherapeutics.

[14]  A. Goyal,et al.  Recent advances in aerosolised drug delivery. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  A. Osterhaus,et al.  Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protection , 2017, npj Vaccines.

[16]  P. Anderson.  History of aerosol therapy: liquid nebulization to MDIs to DPIs. , 2005, Respiratory care.